KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sarepta Therapeutics (SRPT) Other Working Capital Changes: 2013-2025

Historic Other Working Capital Changes for Sarepta Therapeutics (SRPT) over the last 12 years, with Sep 2025 value amounting to $159.9 million.

  • Sarepta Therapeutics' Other Working Capital Changes rose 100.47% to $159.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.5 million, marking a year-over-year increase of 47.81%. This contributed to the annual value of -$32.2 million for FY2024, which is 62.96% up from last year.
  • Per Sarepta Therapeutics' latest filing, its Other Working Capital Changes stood at $159.9 million for Q3 2025, which was up 525.27% from $25.6 million recorded in Q2 2025.
  • In the past 5 years, Sarepta Therapeutics' Other Working Capital Changes registered a high of $159.9 million during Q3 2025, and its lowest value of -$85.4 million during Q1 2025.
  • For the 3-year period, Sarepta Therapeutics' Other Working Capital Changes averaged around -$1.7 million, with its median value being -$20.1 million (2023).
  • In the last 5 years, Sarepta Therapeutics' Other Working Capital Changes slumped by 4,538.14% in 2022 and then skyrocketed by 454.57% in 2024.
  • Sarepta Therapeutics' Other Working Capital Changes (Quarterly) stood at -$29.0 million in 2021, then increased by 22.56% to -$22.5 million in 2022, then increased by 10.74% to -$20.1 million in 2023, then tumbled by 256.31% to -$71.5 million in 2024, then surged by 100.47% to $159.9 million in 2025.
  • Its Other Working Capital Changes stands at $159.9 million for Q3 2025, versus $25.6 million for Q2 2025 and -$85.4 million for Q1 2025.